中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
35期
52-54
,共3页
汤道雄%沈雪梅%罗维%黄可
湯道雄%瀋雪梅%囉維%黃可
탕도웅%침설매%라유%황가
高乌甲素%急腹症%诊断
高烏甲素%急腹癥%診斷
고오갑소%급복증%진단
Lappaconitine%Acute Abdomen%Diagnosis
目的:观察高乌甲素对诊断不明的急腹症患者诊断正确率的影响。方法:采用视觉模拟评分法(VAS)纳入180例中~重度疼痛、诊断不明的急腹症患者,随机分为对照组和高乌甲素组,每组90例。对照组肌注阿托品等对症处理和原发病处理,高乌甲素组除了上述处理外,肌注高乌甲素8 mg,观察两组疼痛评分、主要阳性体征比率和临床诊断正确率。结果:治疗后30 min,对照组VAS为(7.0±1.2)分,高乌甲素组为(5.7±1.4)分,两组比较差异有统计学意义(P<0.05);治疗后2 h,对照组VAS为(5.4±2.3)分,高乌甲素组为(3.2±1.6)分,两组比较差异有统计学意义(P<0.05)。治疗后30 min两组阳性体征比率分别为69%和64%,两组比较差异无统计学意义(P>0.05);治疗后2 h两组阳性体征比率分别为67%和62%,两组比较差异无统计学意义(P>0.05)。两组诊断正确率分别为86.7%和84.4%,比较差异无统计学意义(P>0.05)。结论:高乌甲素镇痛治疗可以减轻患者疼痛,但不影响急腹症的诊断正确率。
目的:觀察高烏甲素對診斷不明的急腹癥患者診斷正確率的影響。方法:採用視覺模擬評分法(VAS)納入180例中~重度疼痛、診斷不明的急腹癥患者,隨機分為對照組和高烏甲素組,每組90例。對照組肌註阿託品等對癥處理和原髮病處理,高烏甲素組除瞭上述處理外,肌註高烏甲素8 mg,觀察兩組疼痛評分、主要暘性體徵比率和臨床診斷正確率。結果:治療後30 min,對照組VAS為(7.0±1.2)分,高烏甲素組為(5.7±1.4)分,兩組比較差異有統計學意義(P<0.05);治療後2 h,對照組VAS為(5.4±2.3)分,高烏甲素組為(3.2±1.6)分,兩組比較差異有統計學意義(P<0.05)。治療後30 min兩組暘性體徵比率分彆為69%和64%,兩組比較差異無統計學意義(P>0.05);治療後2 h兩組暘性體徵比率分彆為67%和62%,兩組比較差異無統計學意義(P>0.05)。兩組診斷正確率分彆為86.7%和84.4%,比較差異無統計學意義(P>0.05)。結論:高烏甲素鎮痛治療可以減輕患者疼痛,但不影響急腹癥的診斷正確率。
목적:관찰고오갑소대진단불명적급복증환자진단정학솔적영향。방법:채용시각모의평분법(VAS)납입180례중~중도동통、진단불명적급복증환자,수궤분위대조조화고오갑소조,매조90례。대조조기주아탁품등대증처리화원발병처리,고오갑소조제료상술처리외,기주고오갑소8 mg,관찰량조동통평분、주요양성체정비솔화림상진단정학솔。결과:치료후30 min,대조조VAS위(7.0±1.2)분,고오갑소조위(5.7±1.4)분,량조비교차이유통계학의의(P<0.05);치료후2 h,대조조VAS위(5.4±2.3)분,고오갑소조위(3.2±1.6)분,량조비교차이유통계학의의(P<0.05)。치료후30 min량조양성체정비솔분별위69%화64%,량조비교차이무통계학의의(P>0.05);치료후2 h량조양성체정비솔분별위67%화62%,량조비교차이무통계학의의(P>0.05)。량조진단정학솔분별위86.7%화84.4%,비교차이무통계학의의(P>0.05)。결론:고오갑소진통치료가이감경환자동통,단불영향급복증적진단정학솔。
Objective:To analyze the effect of lappaconitine on the accuracy of diagnosis in unexplained acute abdomen.Method:Pain was measured with a standard visual analog scale(VAS).180 patients with moderate-severe diagnosis in unexplained acute abdomen were randomized into two groups,the control group and the lappaconitine group respectively,each of 90 patients.8 mg lappaconitine was administered intramuscular for the management of pain in patients in the lappaconitine group.VAS,the ratio of pain sign and clinically diagnostic accuracy were compared.Result:After 30 minutes treatment,VAS were(5.7±1.4)scores in lappaconitine group,while(7.0±1.2)scores in control group ,the difference was statistically significant(P<0.05);the ratio of positive pain sign was 69%in control group and 64%in lappaconitine group,the difference was no statistically significant(P>0.05).After 2 h treatment,VAS were(5.4±2.3)scores in control group and(3.2±1.6)scores in lappaconitine group,the difference was statistically significant(P<0.05);the accuracy of clinically important diagnostic was 86.7% in the control group and 84.4% in the lappaconitine group ,the difference was no statistically significant(P>0.05).Conclusion:Administration of lappaconitine to patients with acute abdominal pain provides analgesia without impairing clinically important diagnostic accuracy.